Brief: X4 Pharmaceuticals Inc Says Believes Has Sufficient Funds To Support Operations Into Q2 Of 2024
04/05/2023 12:34
May 4 (Reuters) - X4 Pharmaceuticals Inc XFOR.O :
* X4 PHARMACEUTICALS INC - BELIEVES HAS SUFFICIENT FUNDS TO
SUPPORT OPERATIONS INTO Q2 OF 2024
* X4 PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.16
Source text for Eikon: ID:
Further company coverage: XFOR.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule